What does CUSIP 45339J204 represent in this 13F holders report?

CUSIP 45339J204 is the security identifier for INDP - Indaptus Therapeutics, Inc. - COM NEW used to aggregate holder disclosures.

How many institutions held INDP - Indaptus Therapeutics, Inc. - COM NEW in Q4 2025?

4 institutional investors reported INDP - Indaptus Therapeutics, Inc. - COM NEW for Q4 2025. Use the holders table for investor-level position and value details.

Indaptus Therapeutics, Inc. - COM NEW (INDP)

CUSIP: 45339J204

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / COM NEW
Total 13F shares: 32,195
Share change: +12,173
Total reported value: $93,687
Price per share: $2.91
Number of holders: 4
Value change: +$35,705
Number of buys: 2
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 45339J204?
CUSIP 45339J204 identifies INDP - Indaptus Therapeutics, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026
Previous quarter: Q3 2025

Recent filing periods for CUSIP 45339J204:

Q1 2026 Q4 2025 Q3 2025 Q2 2025

Top shareholders of INDP - Indaptus Therapeutics, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Glen R. Anderson	3/4/5	10%+ Owner	— class O/S missing	1,190,400	$2,785,536	—	10 Aug 2023	3/4/5
Hoonmo Lee	3/4/5	Director	— mixed-class rows	708,272 mixed-class rows	$1,626,157	—	04 Aug 2021	3/4/5
Michael James Newman	3/4/5 13D/G	CSO and Director, Director · Newman Michael James	5.4% from 13D/G	101,074	$205,180	—	22 Dec 2025	3/4/5 13D/G
Jeffrey A. Meckler	13D/G	Jeffery A. Meckler	13%	273,103	$125,627	$0	22 Dec 2025	13D/G
Walt Addison Linscott	3/4/5	Chief Operating Officer	— class O/S missing	54,426	$110,484	—	22 Dec 2025	3/4/5
Avraham Ben-Tzvi	3/4/5	Director	— mixed-class rows	50,100 mixed-class rows	$68,272	—	23 Dec 2025	3/4/5
Virtu Financial LLC	13F	Company	— class O/S missing	18,997	$55,000	—	30 Sep 2025	13F
Nir Sassi	3/4/5	Chief Financial Officer	— class O/S missing	26,758	$54,318	—	22 Dec 2025	3/4/5
Roger J. Waltzman	3/4/5	Chief Medical Officer	— class O/S missing	75,000	$5,325	—	09 Oct 2024	3/4/5
Boyan Vesselinov Litchev	3/4/5	Chief Medical Officer	— class O/S missing	1,150	$2,691	—	01 Feb 2022	3/4/5
UBS Group AG	13F	Company	— class O/S missing	502	$1,441	—	30 Sep 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	473	$1,358	—	30 Sep 2025	13F
Brian O'Callaghan	3/4/5	Director	— class O/S missing	13,750	$976	—	30 Sep 2022	3/4/5
Mark J. Gilbert	3/4/5	Director	— class O/S missing	12,500	$888	—	10 Jun 2025	3/4/5
Robert Martell	3/4/5	Director	— class O/S missing	12,500	$888	—	10 Jun 2025	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	33	$94	—	30 Sep 2025	13F
SBI Securities Co., Ltd.	13F	Company	— class O/S missing	17	$49	—	30 Sep 2025	13F
Roger Pomerantz	3/4/5	Director	— class O/S missing	30,000	—	—	10 Jun 2025	3/4/5
Anthony J. Maddaluna	3/4/5	Director	— class O/S missing	12,500	—	—	10 Jun 2025	3/4/5
Hila Karah	3/4/5	Director	— class O/S missing	12,500	—	—	10 Jun 2025	3/4/5
William B. Hayes	3/4/5	Director	— class O/S missing	12,500	—	—	10 Jun 2025	3/4/5

Institutional Holders of Indaptus Therapeutics, Inc. - COM NEW (INDP) as of Q4 2025

As of 31 Dec 2025, Indaptus Therapeutics, Inc. - COM NEW (INDP) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,195 shares. The largest 4 holders included UBS Group AG, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and SBI Securities Co., Ltd.. This page lists 4 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

-1

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.